Cargando…
Ivermectin Augments the Anti-Cancer Activity of Pitavastatin in Ovarian Cancer Cells
We have previously shown that pitavastatin has the potential to be used to treat ovarian cancer, although relatively high doses are likely to be necessary. One solution to this problem is to identify drugs that are synergistic with pitavastatin, thereby reducing the dose that is necessary to have a...
Autores principales: | Jawad, Mohammed Jasim, Richardson, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047003/ https://www.ncbi.nlm.nih.gov/pubmed/36975598 http://dx.doi.org/10.3390/diseases11010049 |
Ejemplares similares
-
Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells
por: Abdullah, Marwan Ibrahim, et al.
Publicado: (2017) -
Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death
por: Abdullah, Marwan Ibrahim, et al.
Publicado: (2019) -
Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma
por: Nunes, Mariana, et al.
Publicado: (2022) -
Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer
por: de Wolf, Elizabeth, et al.
Publicado: (2017) -
Pitavastatin suppressed liver cancer cells in vitro and in vivo
por: You, He-Yi, et al.
Publicado: (2016)